FIRST EXTENSION - GRANTED
granted
on 03 Jul 2024
Last Applicant/ Owned by
3-5-1, Nihonbashi Honcho
Chuo-ku, Tokyo
JP
103-8426
Serial Number
97718835 filed on 15th Dec 2022
Registration Number
N/A
Correspondent Address
Bassam N. Ibrahim
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LYNRUXTI
Pharmaceutical preparations and products for use in the prevention or treatment of cancer, carcinoma, tumors, oncological disease, leukemia, metastasis, mesothelioma, myeloma, sarcoma, lymphoma, neuroblastoma
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and products for use in the prevention or treatment of cancer, carcinoma, tumors, oncological disease, leukemia, metastasis, mesothelioma, myeloma, sarcoma, lymphoma, neuroblastoma
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97718835
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 0076404-241
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Jul 2024 | SOU EXTENSION 1 FILED |
| 03rd Jul 2024 | SOU EXTENSION 1 GRANTED |
| 03rd Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd Jul 2024 | SOU TEAS EXTENSION RECEIVED |
| 06th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Dec 2023 | PUBLISHED FOR OPPOSITION |
| 22nd Nov 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 06th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 06th Nov 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |